ArticleClinical drug investigation2020

Could Tocilizumab be an Attractive Therapeutic Option for Elderly Patients with Severe COVID-19? A Case Report.

Caroline Streicher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.